FDA Inspection 1116650 — BioLife Plasma Services LP

BioLife Plasma Services LP — FEI 1978019

The FDA completed an inspection of BioLife Plasma Services LP on January 31, 2020 in Springfield, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 31, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Springfield, MO (United States)